reports
Stryker reports first quarter 2024 operating results
Stryker reports first quarter 2024 operating results Portage, Michigan, April 30, 2024 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) reported operating results for the first quarter of 2024: First Quarter Results Reported net sales increased 9.7% to $5.2 billionOrganic net sales increased 10.0%Reported operating income margin of 18.5%Adjusted operating income margin(1) increased 80 bps to 21.9%Reported EPS increased 33.1% to $2.05Adjusted EPS(1) increased 16.8% to $2.50 First Quarter Net Sales Growth Overview Reported Foreign Currency Exchange Constant Currency Acquis...
Edwards Lifesciences to Host Earnings Conference Call on April 25, 202...
IRVINE, Calif.--(BUSINESS WIRE)-- Edwards Lifesciences (NYSE: EW) plans to announce its operating results for the quarter ended March 31, 2024 after the market closes on Thursday, April 25, 2024, and will host a conference call at 5:00 p.m. ET that day to discuss those results. To participate in the conference call, dial (877) 704-2848 or (201) 389-0893. The call will also be available live and archived on the “Investor Relations” section of the Edwards website at . About Edwards Lifesciences Edwards Lifesciences, is the global leader of patient-focused innovations for structural heart d...
Stryker to announce financial results for its first quarter of fiscal ...
Stryker to announce financial results for its first quarter of fiscal year 2024 Portage, Michigan, April 01, 2024 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that it will report financial results for first quarter of fiscal year 2024 on Tuesday, April 30, 2024. A press release will be issued at approximately 4:05pm ET and available at that day. The press release will include summary financial information for the company’s first quarter of fiscal year 2024, that ended March 31, 2024. Stryker will host a webcast at 4:30pm ET on Tuesday, April 30, to discuss results for its first quar...
Stryker announces Annual Meeting of Shareholders
Stryker announces Annual Meeting of Shareholders Portage, Michigan, March 26, 2024 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced its 2024 Annual Meeting of Shareholders is scheduled as follows: Thursday, May 9, 2024 – 9:30 a.m. Eastern Time The Meeting will be held virtually via the internet. Information about the webcast, which will include both the audio and the slide presentation from the meeting, is available on the Investor Relations page of our website at To listen to the meeting as a guest dial (877) 328-2502 (U.S.) or (412) 317-5419 (International) and request the "Stryker...
Moody's affirms Stryker Corporation's Baa1 senior unsecured rating, re...
Moody's Ratings (Moody's) affirmed Stryker Corporation's ("Stryker") Baa1 senior unsecured ratings, Baa1 long term issuer rating, and the company's Prime-2 commercial paper rating. At the same time, Moody's revised the outlook to positive from stable. The affirmation of Stryker's ratings reflects ...
Edwards Lifesciences to Present at the 44th Annual TD Cowen Healthcare...
IRVINE, Calif.--(BUSINESS WIRE)-- Edwards Lifesciences Corporation (NYSE: EW) today announced it will participate in the TD Cowen Healthcare Conference on Tuesday, March 5, 2024. Bernard Zovighian, chief executive officer, and Scott Ullem, chief financial officer, are scheduled to present at 10:30 a.m. ET. A live webcast of the presentation will be available on the Edwards Lifesciences investor relations website at , with an archived version accessible later the same day. About Edwards Lifesciences Edwards Lifesciences is the global leader of patient-focused innovations for structural he...
Stryker Corp: 1 director
A director at Stryker Corp sold 9,600 shares at 342.808USD and the significance rating of the trade was 77/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly sh...
Stryker declares a $0.80 per share quarterly dividend
Stryker declares a $0.80 per share quarterly dividend Portage, Michigan, Feb. 07, 2024 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.80 per share payable April 30, 2024 to shareholders of record at the close of business on March 29, 2024, representing an increase of 6.7% versus the prior year and unchanged from the previous quarter. About Stryker Stryker is a global leader in medical technologies and, together with its customers, is driven to make healthcare better. The company offers innovative products and servic...
Edwards Lifesciences Reports Fourth Quarter Results
IRVINE, Calif.--(BUSINESS WIRE)-- Edwards Lifesciences (NYSE: EW) today reported financial results for the quarter ended December 31, 2023. Highlights and Outlook Q4 sales grew 14 percent to $1.53 billion; constant currency1 sales grew 13 percent Q4 TAVR sales grew 13 percent; constant currency sales grew 12 percent Q4 EPS of $0.61; adjusted1 EPS of $0.64 2023 sales of $6.0 billion grew 12 percent; EPS of $2.30; adjusted EPS of $2.51 Completed enrollment early in PROGRESS pivotal trial, studying moderate AS patients Received early FDA approval for EVOQUE; ongoing European l...
Stryker to participate in Citi’s 2024 Unplugged Medtech and Life Scien...
Stryker to participate in Citi’s 2024 Unplugged Medtech and Life Sciences Access Day Portage, Michigan, Feb. 05, 2024 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) will participate in Citi’s 2024 Unplugged Medtech and Life Sciences Access Day on Thursday, February 29, 2024 at Citigroup Headquarters, New York, New York. Glenn Boehnlein, Vice President, Chief Financial Officer and Jason Beach, Vice President, Investor Relations will represent the Company in a presentation scheduled for 1:45 p.m. Eastern Time. A simultaneous webcast and replay of the Company’s presentation will be available on St...
Stryker reports 2023 operating results and 2024 outlook
Stryker reports 2023 operating results and 2024 outlook Portage, Michigan, Jan. 30, 2024 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) reported operating results for the fourth quarter and full year of 2023: Fourth Quarter Results Reported net sales increased 11.8% to $5.8 billionOrganic net sales increased 11.4%Reported operating income margin of 21.6%Adjusted operating income margin(1) increased 60 bps to 27.2%Reported EPS increased 102.7% to $2.98Adjusted EPS(1) increased 15.3% to $3.46 Fourth Quarter Net Sales Growth Overview Reported Foreign Currency Exchange Constant...
Edwards Lifesciences to Host Earnings Conference Call on February 6, 2...
IRVINE, Calif.--(BUSINESS WIRE)-- Edwards Lifesciences (NYSE: EW) plans to announce its operating results for the quarter ended December 31, 2023 after the market closes on Tuesday, February 6, 2024, and will host a conference call at 5:00 p.m. ET that day to discuss those results. To participate in the conference call, dial (877) 704-2848 or (201) 389-0893. The call will also be available live and archived on the “Investor Relations” section of the Edwards website at . About Edwards Lifesciences Edwards Lifesciences, is the global leader of patient-focused innovations for structural hea...
Stryker announces 2023 sales surpassed $20 billion
Stryker announces 2023 sales surpassed $20 billion Portage, Michigan, Jan. 08, 2024 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced today that it surpassed $20 billion in annual sales for the first time in its history during the month of December, 2023. “We are excited to surpass this major milestone and to share with our employees as we have our kick-off meetings for 2024,” said Kevin Lobo, Chair and Chief Executive Officer. “This means that we are positively impacting more customers and patients than ever.” Stryker will disclose additional information regarding its 2023 financi...
Stryker to announce financial results for its fourth quarter and full ...
Stryker to announce financial results for its fourth quarter and full year 2023 Portage, Michigan, Jan. 05, 2024 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that it will report financial results for fourth quarter and full year 2023 on Tuesday, January 30, 2024. A press release will be issued at approximately 4:05pm ET and available at that day. The press release will include summary financial information for the company’s fourth quarter and full year 2023, that ended December 31, 2023. Stryker will host a webcast at 4:30pm ET on Tuesday, January 30, 2024, to discuss results for ...
Medtronic Plc: 1 director
A director at Medtronic Plc sold 4,997 shares at 82.170USD and the significance rating of the trade was 57/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly sh...
Moody's says Edward's planned spinoff of its Critical Care business re...
Moody's Investors Service ("Moody's") said that Edwards Lifesciences Corporation's ("Edwards") announced spin-off of its Critical Care Business will reduce the company's overall diversity and scale. The Critical Care business represents approximately 15% of Edwards' total revenue (year-to-date as of...
Stryker announces intention to nominate a new director, Rachel Ruggeri
Stryker announces intention to nominate a new director, Rachel Ruggeri Kalamazoo, Michigan, Dec. 07, 2023 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced today that its Board of Directors intends to nominate Rachel Ruggeri for election to the Company’s Board of Directors at Stryker’s 2024 Annual Meeting of Shareholders, which is expected to be held on May 9, 2024. Ms. Rachel Ruggeri has over 25 years of global finance leadership experience and serves as the executive vice president and chief financial officer at Starbucks, where she is responsible for the global finance function for th...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.